Cambiar Investors LLC cut its position in shares of CVS Health Corporation (NYSE:CVS) by 2.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 895,684 shares of the pharmacy operator’s stock after selling 22,967 shares during the period. CVS Health Corporation makes up 1.2% of Cambiar Investors LLC’s portfolio, making the stock its 27th largest position. Cambiar Investors LLC owned 0.08% of CVS Health Corporation worth $85,753,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the stock. Retirement Systems of Alabama increased its position in CVS Health Corporation by 8.7% in the second quarter. Retirement Systems of Alabama now owns 1,043,349 shares of the pharmacy operator’s stock worth $99,890,000 after buying an additional 83,608 shares during the last quarter. Atwood & Palmer Inc. increased its position in CVS Health Corporation by 1.5% in the second quarter. Atwood & Palmer Inc. now owns 202,127 shares of the pharmacy operator’s stock worth $19,352,000 after buying an additional 3,059 shares during the last quarter. TIAA CREF Trust Co. FSB MO increased its position in CVS Health Corporation by 2.5% in the second quarter. TIAA CREF Trust Co. FSB MO now owns 200,005 shares of the pharmacy operator’s stock worth $19,149,000 after buying an additional 4,913 shares during the last quarter. Sentry Investments Corp. increased its position in CVS Health Corporation by 6.3% in the first quarter. Sentry Investments Corp. now owns 2,179,600 shares of the pharmacy operator’s stock worth $226,090,000 after buying an additional 128,300 shares during the last quarter. Finally, Lodestar Investment Counsel LLC IL increased its position in CVS Health Corporation by 4.2% in the second quarter. Lodestar Investment Counsel LLC IL now owns 176,387 shares of the pharmacy operator’s stock worth $16,887,000 after buying an additional 7,136 shares during the last quarter. 80.95% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) traded up 1.24% during mid-day trading on Wednesday, hitting $87.47. 6,952,362 shares of the stock were exchanged. CVS Health Corporation has a 1-year low of $85.41 and a 1-year high of $106.67. The company has a market capitalization of $93.26 billion, a PE ratio of 20.12 and a beta of 0.83. The stock has a 50 day moving average price of $90.79 and a 200 day moving average price of $96.67.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.02. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. The company earned $43.70 billion during the quarter, compared to the consensus estimate of $44.28 billion. During the same quarter in the prior year, the firm posted $1.19 earnings per share. The firm’s revenue was up 17.6% compared to the same quarter last year. On average, equities analysts anticipate that CVS Health Corporation will post $5.86 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 3rd. Shareholders of record on Monday, October 24th will be given a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a yield of 1.94%. The ex-dividend date of this dividend is Thursday, October 20th. CVS Health Corporation’s dividend payout ratio is presently 39.08%.

A number of brokerages recently issued reports on CVS. Deutsche Bank AG increased their target price on shares of CVS Health Corporation from $99.00 to $105.00 and gave the stock a “hold” rating in a research report on Wednesday, June 22nd. Argus reiterated a “buy” rating and set a $120.00 target price on shares of CVS Health Corporation in a research report on Thursday, August 4th. Leerink Swann reiterated a “buy” rating on shares of CVS Health Corporation in a research report on Wednesday, August 3rd. Zacks Investment Research upgraded shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 3rd. Finally, Mizuho increased their target price on shares of CVS Health Corporation from $108.00 to $111.00 and gave the stock a “buy” rating in a research report on Thursday, August 4th. Five research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $112.40.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

5 Day Chart for NYSE:CVS

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.